We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Agrees to Provide Grassley With Information on Ketek Review
FDA Agrees to Provide Grassley With Information on Ketek Review
May 24, 2006
Just days after missing a deadline set by Sen. Chuck Grassley (R-Iowa) for a briefing related to its controversial approval of the antibiotic Ketek, the FDA informed the Senate Finance Committee chairman in the middle of May that it would provide him with all the information he had requested on the review of the drug.